Amur Minerals Corporation Suspension of trading on AIM (6375L)
September 07 2023 - 1:00AM
UK Regulatory
TIDMAMC
RNS Number : 6375L
Amur Minerals Corporation
07 September 2023
7 September 2023
Amur Minerals Corporation
("Amur" or the "Company")
Suspension of trading on AIM
Amur Minerals Corporation (AIM: AMC) confirms that trading in
the Company's shares on AIM will be suspended with effect from 7.30
a.m. BST today.
As stated in the Company's notification of 6 March 2023,
following the disposal of the Company's AO Kun-Manie subsidiary,
Amur became classified as an AIM Rule 15 cash shell from that date,
and as such was required to make an acquisition or acquisitions
which would constitute a reverse takeover under Rule 14 of the AIM
Rules for Companies, or be re-admitted on AIM as an investing
company under the AIM Rules on or before the date falling six
months from 6 March 2023.
As neither a reverse takeover nor readmission to trading on AIM
as an investing company have been completed, trading in the
Company's shares on AIM will now be suspended today.
Trading will remain suspended until the completion of a reverse
takeover, which requires the publication of an admission document
and the approval of such a transaction at a General Meeting of the
Company, or the Company is readmitted to trading on AIM as an
investing company.
If no such transaction is completed within six months, the
Company's shares will be cancelled from trading on AIM pursuant to
AIM Rule 41. There can be no assurance that the Company will be
able to complete a reverse takeover during the six-month suspension
period.
The board of Amur continues to review a number of reverse
takeover opportunities. Further announcements will be made as
appropriate.
Enquiries:
Company Nomad and Broker Public Relations
Amur Minerals Corp. S.P. Angel Corporate BlytheRay
Finance LLP
Robin Young CEO Richard Morrison Megan Ray
Adam Cowl Tim Blythe
+44 (0) 20 3470
+44 (0) 7981 126 818 0470 +44 (0) 20 7138 3203
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCDGGDCSXGDGXL
(END) Dow Jones Newswires
September 07, 2023 02:00 ET (06:00 GMT)
Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024